Lipocine
(NASDAQ) LPCN
Lipocine Financials at a Glance
Market Cap
$16.72M
Revenue (TTM)
$1.98M
Net Income (TTM)
$9.63M
EPS (TTM)
$-1.77
P/E Ratio
-1.30
Dividend
$0.00
Beta (Volatility)
0.78 (Low)
Dividend
$0.00
Beta (Volatility)
0.78 (Low)
Price
$2.32
Volume
788
Open
$2.25
Price
$2.32
Volume
788
Open
$2.25
Previous Close
$2.32
Daily Range
$2.24 - $2.32
52-Week Range
$1.81 - $12.37
Dividend
$0.00
Beta (Volatility)
0.78 (Low)
Price
$2.32
Volume
788
Open
$2.25
Previous Close
$2.32
Daily Range
$2.24 - $2.32
52-Week Range
$1.81 - $12.37
LPCN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lipocine
Industry
Pharmaceuticals
Sector
Health CareEmployees
14
CEO
Mahesh V. Patel, PhD
Website
www.lipocine.comHeadquarters
Salt Lake City, UT 84108, US
LPCN Financials
Key Financial Metrics (TTM)
Gross Margin
-9%
Operating Margin
-5%
Net Income Margin
-5%
Return on Equity
-54%
Return on Capital
-72%
Return on Assets
-57%
Earnings Yield
-76.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.72M
Shares Outstanding
7.30M
Volume
788
Avg. Volume
400.26K
Financials (TTM)
Gross Profit
$6.61M
Operating Income
$10.37M
EBITDA
$10.31M
Operating Cash Flow
$9.76M
Capital Expenditure
$0.00
Free Cash Flow
$9.76M
Cash & ST Invst.
$14.93M
Total Debt
$0.00
Lipocine Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.15M
-67.2%
Gross Profit
$1.13M
-67.6%
Gross Margin
98.69%
N/A
Market Cap
$16.72M
N/A
Market Cap/Employee
$1.04M
N/A
Employees
16
N/A
Net Income
$2.37M
-233.0%
EBITDA
$2.50M
-260.3%
Quarterly Fundamentals
Net Cash
$14.93M
-31.0%
Accounts Receivable
$14.19K
-88.2%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-56.61%
N/A
Return on Invested Capital
-71.64%
N/A
Free Cash Flow
$2.92M
-272.6%
Operating Cash Flow
$2.92M
-271.5%